title: Double-blind, controlled trial of inositol treatment of depression.
abstract: OBJECTIVE
  CSF levels of inositol have been reported to be lower than normal in depressed subjects. The authors administered inositol to depressed patients in a double-blind, controlled trial.
  
  
  METHODS
  Under double-blind conditions, 12 g/day of inositol (N = 13) or placebo (N = 15) was administered to depressed patients for 4 weeks.
  
  
  RESULTS
  The overall improvement in scores on the Hamilton Depression Rating Scale was significantly greater for inositol than for placebo at week 4. No changes were noted in hematology or in kidney or liver function.
  
  
  CONCLUSIONS
  This may be the first use of the precursor strategy for a second messenger rather than a neurotransmitter in treating depression. Although inositol had a significant antidepressant effect in this study, replication is crucial.
authors.affiliation: Yehuda Abarbanel Mental Health Center, Bat Yam, Israel.
authors.forename: J
authors.initials: J
authors.lastname: Levine
authors.forename: Y
authors.initials: Y
authors.lastname: Barak
authors.forename: M
authors.initials: M
authors.lastname: Gonzalves
authors.forename: H
authors.initials: H
authors.lastname: Szor
authors.forename: A
authors.initials: A
authors.lastname: Elizur
authors.forename: O
authors.initials: O
authors.lastname: Kofman
authors.forename: R H
authors.initials: RH
authors.lastname: Belmaker
mesh_terms: D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D016896:Treatment Outcome
chemical_list: D010919:Placebos; D007294:Inositol